Our Blog

Neuroimaging in 2021

Neuroimaging in 2021 – Mild Traumatic Brain Injury (mTBI) – Unlocking the complexities: Webinar for  The Brain Injury Group   Dr Emer MacSweeney, Medical Director and Consultant […]

“Spotting the Early Signs and Supporting Your Patients” – Oryon Develop webinar

Dr Emer MacSweeney presented an Oryon Develop webinar on “Alzheimer’s – Spotting the Early Signs and Supporting Your Patients” targeted at healthcare practitioners.   The comprehensive presentation […]

CHUMS CHARITY

Our team at Re:Cognition Health is  passionate to support the health and learning of children and young people. Prior to the pandemic, one in nine children and […]

The Spectrum of Alzheimer’s

The Spectrum of Alzheimer’s   A recent study, undertaken by a Re:Cognition Health USA Principal Investigator Dr R. Scott Turner, confirms that both Mild Cognitive Impairment (MCI) […]

Linda & Barry Key

      Mrs Linda Key is the wife and study partner of Mr Barry Key who was diagnosed with Alzheimer’s at the age of 71. Mr […]

Parkinson’s Disease and Exercise

We all know that  exercise is a crucial component of a healthy lifestyle. Importantly, research has shown that exercise can provide a significant improvement in motor symptoms […]

Clinical Trials Volunteer – Mrs Ruth Chauhan

Mrs Ruth Chauhan Case Study: Clinical Trials Volunteer Mrs Ruth Chauhan was diagnosed with Mild Cognitive Impairment at the age of 68. In May 2020, Ruth registered […]

Alzheimer’s Show Digital Hub

Join Dr Emer MacSweeney on the Alzheimer’s Show Digital Hub on Wednesday, 27th January at midday where she will be talking about the exciting recent research developments […]

Health Tech World Explores DTI technology

Dr Emer MacSweeney speaks with Health Tech World about the DTI imaging to provide  objective evidence of  CTE in international rugby players.   Dr MacSweeney explains how […]

Future of Healthcare webinar

Dr Emer MacSweeney, CEO and Medical Director at Re:Cognition Health was delighted to speak  at the Future of Healthcare webinar hosted by Cushman and Wakefield and VWV on Alzheimer’s Disease […]